Changing the Future of PNH Care Through Global Collaboration – The Max Foundation
The Max Foundation shared a post on LinkedIn:
“For physicians like Dr. Mipsang Lama in Nepal, there was a time when the rare and devastating blood disorder of Paroxysmal Nocturnal Hemoglobinuria (PNH) could be identified but not truly treated.
Care meant repeated transfusions, temporary stabilization, and watching patients live with constant uncertainty.
Then, thanks to our partnership with Novartis Global Health and the International PNH Interest Group, access to treatment and training changed that!
Within weeks, patients began regaining strength. Conversations shifted from survival to possibility.
For Dr. Lama, it was more than a clinical change. It was the ability to finally offer hope alongside care.
He shared, ‘To those working in global health and rare disease access, your work has a deeply human impact. PNH may be rare, but the suffering it causes is real and significant. Today, for the first time, we can say with confidence that ‘it is treatable.’ ”

Stay updated with Hemostasis Today.
-
May 17, 2026, 11:04Owen McCarty: Few Insights and Implications from Recent Clinical Trials of FXI Inhibitors
-
May 17, 2026, 10:55National Phlebotomist Week and the People Powering Patient Care – Northwell Health
-
May 17, 2026, 10:54Amanda Unsworth: Discovering Heart and Thrombosis Science at Be Curious
-
May 17, 2026, 10:50Urs Fischer: Could a Three-in-One Pill Improve Outcomes After Brain Bleeding
-
May 17, 2026, 10:50CAR T-Cell Therapy and Life-Changing Progress in Autoimmune Disease – UNC Health
-
May 17, 2026, 10:18Shashank Joshi: Improved Functional Recovery After Stroke With Adjunctive Alteplase
-
May 17, 2026, 06:26The Long-Term Organ-Specific Complications of Nonextremity Thrombosis in Children – JTH
-
May 17, 2026, 04:41Rob Maloney: Hemophilia of Georgia Exists to Build the Support System Around People Living with Bleeding Disorders
-
May 17, 2026, 04:36Purusotham Chippala: Hemineglect Is One of The Most Misunderstood Conditions After Stroke